Nova biomedical was made aware of a customer event that took place utilizing a statstrip glucose meter on a neonate on december 12, 2020 by the fda via postal mail.There has been no communication directly from the customer regarding this event.Nova inquired to the fda if additional information could be provided and was informed that the reporter identity is confidential.A complaint sample was not returned to nova and no serial or lot number information has been provided; therefore, an evaluation of the device could not be performed and manufacturing records could not be reviewed.There is also no information pertaining to any alleged patient harm or intervention.The cause(s) of the difficulty reported by the fda could not be determined or if there were several events.This complaint will be closed as 'no complaint sample returned to nova for evaluation'.If the complaint sample and or additional information regarding this event becomes available, this complaint will be reopened, and the respective evaluation performed.No corrective action is required based on the above information.
|